China driving global pharma growth
October 13, 2010Sales and Marketing China, emerging markets, sales
The global pharma market is forecast to reach $880 billion by 2011, driven by growth in the Chinese market. Analysts …
Pfizer acquires King Pharmaceuticals for $3.6bn
October 13, 2010Sales and Marketing King Pharmaceuticals, Pfizer, pain therapeutics
Pfizer is to purchase King Pharmaceuticals for $3.6 billion to significantly strengthen its pain portfolio and continue to diversify its …
NICE unmoved on Takeda bone cancer drug
October 13, 2010Sales and Marketing Mepact, NICE, Takeda
NICE has refused to recommend Takeda’s Mepact because of its “exceptionally high cost” and the “substantial uncertainty” about the osteosarcoma …
Philip Vickers joins Shire
October 13, 2010Research and Development Shire, appointment, research and development
Shire has appointed Philip Vickers as senior VP of research and development for its Human Genetic Therapies (HGT) business. He …
Digital Pharma: Genzyme’s augmented reality heart
October 12, 2010Medical Communications Digital Pharma blog, Genzyme, augmented reality
Genzyme Europe has launched a new website that allows users to take a peak inside their own heart, or so …
Pharmsynthez boosts board
October 12, 2010Manufacturing and Production, Research and Development Pharmsynthez, appointment, manufacturing and production, research and development
Moscow-based pharmaceutical company JSC Pharmsynthez has appointed Miroslav Ravic and Howard Fisher to its board as independent non-executive directors. Miroslav …
UCB signs Parkinson’s research deal
October 12, 2010Research and Development Parkinson's, Synosia Therapeutics, UCB, neurology
UCB has partnered with Synosia Therapeutics to develop two of the Swiss firm’s compounds for Parkinson’s disease. Basel-based Synosia has …
Stem cell trial re-starts
October 12, 2010Research and Development Geron, Stem cells, spinal injury
Geron Corporation has enrolled the first patient in its restarted clinical trial of human embryonic stem cells (hESC). The world’s …
Making the most of outsourcing and offshoring
October 12, 2010Manufacturing and Production, Research and Development Kinapse, outsourcing
As the budgets of pharma companies face continued downward pressure, the objective of outsourcing is not only to find effective …
Merck will appeal EMA’s Movectro decision
October 12, 2010Sales and Marketing CHMP, EMA, Merck KGaA, Merck Serono, Movectro
Merck KGaA is poised to appeal the EMA’s decision on its MS treatment Movectro after the regulator rejected the drug …
UniversalProcon expands UK team
October 11, 2010Sales and Marketing UniversalProcon, appointment, sales and marketing
Transatlantic event management company UniversalProcon has expanded its UK operations with five new appointments. Sophie Limbert (pictured) joins as a …
ABPI’s Barker to step down
October 11, 2010Sales and Marketing ABPI, appointment, sales and marketing
ABPI director general Dr Richard Barker is to step down in 2011 after six years at the helm of the …
Abbott withdraws anti-obesity drug amid safety worries
October 11, 2010Sales and Marketing Abbott, Meridia, obesity
Abbott has pulled its anti-obesity drug Meridia in the US after recent trials showed it increased the risk of stroke …
Treasure trove of cancer information on tap for GPs
October 11, 2010Medical Communications Cancer, Doctors.net.uk, GP, cancer care, online community, professional network
Cancer Research UK appoints Doctors.net to launch campaign to raise awareness of the charity’s vast information resources for GPs
Boehringer pulls ‘Pink Viagra’
October 11, 2010Sales and Marketing Boehringer, Girosa
Boehringer Ingelheim has discontinued development of its hypoactive sexual desire disorder drug Girosa after the FDA refused to approve it. …
Sanofi slashes US workforce
October 11, 2010Sales and Marketing Sanofi-Aventis, job cuts
Sanofi-Aventis is to cut a quarter of its workforce in the US – making 1,700 people redundant – as it …
Novartis eyes genomics route for flu vaccines
October 11, 2010Manufacturing and Production, Research and Development Novartis, Synthetic Genomics Vaccines, genomics
Novartis will make use of a technology developed by Synthetic Genomics Vaccines, a new company set up by genomics pioneer …
Fleishman appoints Henry Featherstone
October 8, 2010Medical Communications Fleishman, appointment, medical communications
Henry Featherstone has joined Fleishman-Hillard’s London healthcare public affairs and corporate communications team as a senior policy adviser. He moves …
Digital Pharma: Facebook first from Janssen
October 8, 2010Medical Communications Digital Pharma blog, Facebook, Janssen, Twitter, ipad, iphone, youtube
Janssen UK has officially launched its new psoriasis disease awareness campaign, part of which includes the first pharma Facebook page …
NHS reforms moving ‘too fast’
October 8, 2010NHS, government, king's fund
The government’s plans to reform the NHS are moving too far according to health think tank the King’s Fund. Radical …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
